Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 26, 2025 $896.18 -0.62% $915.01 X 97.94% 0
Feb 26, 2025 Bullish $915.01 V 1
Feb 24, 2025 $864.94 -1.00% $881.40 X 98.13% 0
Feb 24, 2025 $868.22 -0.62% $881.40 X 98.50% 1
vlamanchev vlamanchev Amateur
Feb 24, 2025 Bullish $881.40 V 1
Feb 24, 2025 $873.12 +0.00% $881.40 X 99.06% 1
Feb 12, 2025 $856.06 -1.03% $872.97 X 98.06% 0
Feb 12, 2025 $859.41 -0.65% $872.97 X 98.45% 0
Feb 12, 2025 Bullish $872.97 V 1
Feb 11, 2025 $859.67 -1.06% $865.00 V 99.38% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE